Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-31 4:23 pm Sale | 2024-05-13 | 13G | Turnstone Biologics Corp. TSBX | Langer Timothy | 993,607 4.300% | -299,613 (-23.17%) | Filing History |
| 2024-04-29 08:22 am Sale | 2024-04-26 | 13G | Turnstone Biologics Corp. TSBX | FMR LLC | 1,386,323 5.994% | -1,160,338 (-45.56%) | Filing History |
| 2024-03-18 9:13 pm Purchase | 2023-09-11 | 13G | Turnstone Biologics Corp. TSBX | Langer Timothy | 1,293,220 5.600% | 1,293,220 (New Position) | Filing History |
| 2024-02-09 10:05 am Sale | 2024-02-08 | 13G | Turnstone Biologics Corp. TSBX | FMR LLC | 2,546,661 11.027% | -372,126 (-12.75%) | Filing History |
| 2023-08-03 4:41 pm Purchase | 2023-07-25 | 13D | Turnstone Biologics Corp. TSBX | Versant Venture Capital V L.P. | 2,899,216 12.500% | 2,899,216 (New Position) | Filing History |
| 2023-07-27 4:20 pm Purchase | 2023-07-25 | 13G | Turnstone Biologics Corp. TSBX | Point72 Asset Management L.P. | 1,383,314 6.200% | 1,383,314 (New Position) | Filing History |
| 2023-07-27 08:57 am Purchase | 2023-07-27 | 13G | Turnstone Biologics Corp. TSBX | FMR LLC | 2,918,787 13.154% | 2,918,787 (New Position) | Filing History |
| 2023-07-24 4:33 pm Purchase | 2023-07-20 | 13D | Turnstone Biologics Corp. TSBX | ORBIMED ADVISORS LLC | 3,099,265 13.400% | 3,099,265 (New Position) | Filing History |